Pharmacokinetics of ertapenem following intravenous and subcutaneous infusions in patients

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 924-926

  Frasca, Denis ^a,c   Marchand, Sandrine ^a,b,c   Petitpas, Franck ^a,c   Dahyot Fizelier, Claire ^a,b,c   Couet, William ^a,b,c   Mimoz, Olivier ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERTAPENEM;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SIMULATION; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, SUBCUTANEOUS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; YOUNG ADULT;

EID: 75749154990     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00836-09     Document Type: Article

References (23)

1. Barbot, A., N. Venisse, F. Rayeh, S. Bouquet, B. Debaene, and O. Mimoz. 2003. Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors. Intensive Care Med. 29:1528-1534.
2. Boselli, E., D. Breilh, M. C. Saux, J. B. Gordien, and B. Allaouchiche. 2006. Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia. Intensive Care Med. 32:2059-2062.
3. Brink, A. J., G. A. Richards, V. Schillack, S. Kiem, and J. Schentag. 2008. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. Int. J. Antimicrob. Agents 33:432-436.
4. Burkhardt, O., M. Brunner, S. Schmidt, M. Grant, Y. Tang, and H. Derendorf. 2006. Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis. J. Antimicrob. Chemother. 58:632-636.
5. Burkhardt, O., H. Derendorf, and T. Welte. 2007. Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice. Expert Opin. Pharmacother. 8:237-256.
6. Burkhardt, O., C. Hafer, A. Langhoff, V. Kaever, V. Kumar, T. Welte, H. Haller, D. Fliser, and J. T. Kielstein. 2009. Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis. Nephrol. Dial. Transplant. 24:267-271.
7. Burkhardt, O., V. Kumar, D. Katterwe, J. Majcher-Peszynska, B. Drewelow, H. Derendorf, and T. Welte. 2007. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration. J. Antimicrob. Chemother. 59: 277-284.
8. Chen, M., A. N. Nafziger, G. L. Drusano, L. Ma, and J. S. Bertino, Jr. 2006. Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults. Antimicrob. Agents Chemother. 50:1222-1227.
9. Craig, W. 2002. Pharmacodynamics of antimicrobials: general concepts and application, p. 1-22. In C. H. Nightingale, M. T. Murakawa, and P. G. Ambrose (ed.), Antimicrobial pharmacodynamics in theory and clinical practice. Marcel-Dekker, New York, NY.
10. Dinubile, M. J., I. R. Friedland, C. Y. Chan, M. R. Motyl, H. Giezek, K. McCarroll, M. Shivaprakash, J. P. Quinn, R. A. Weinstein, and J. W. Chow. 2007. Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy. Diagn. Microbiol. Infect. Dis. 58:491-494.
11. Fonzo-Christe, C., C. Vukasovic, A. F. Wasilewski-Rasca, and P. Bonnabry. 2005. Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review. Palliat. Med. 19:208-219.
12. Lefeuvre, S., N. Venisse, S. Marchand, M. Bachelet, and W. Couet. 2008. A simple and sensitive liquid chromatography-tandem mass spectrometry assay for the quantification of ertapenem in microdialysate. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 862:242-245.
13. Legua, P., J. Lema, J. Moll, Q. Jiang, G. Woods, and I. Friedland. 2002. Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone. Clin. Ther. 24:434-444.
14. Liu, P., and H. Derendorf. 2003. Antimicrobial tissue concentrations. Infect. Dis. Clin. North Am. 17:599-613.
15. Majumdar, A. K., D. G. Musson, K. L. Birk, C. J. Kitchen, S. Holland, and J. McCrea. 2002. Pharmacokinetics of ertapenem in healthy young volunteers. Antimicrob. Agents Chemother. 46:3506-3511.
16. Mistry, G. C., A. K. Majumdar, S. Swan, D. Sica, A. Fisher, Y. Xu, M. Hesney, L. Xi, J. A. Wagner, and P. J. Deutsch. 2006. Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis. J. Clin. Pharmacol. 46:1128-1138.
17. Mouton, J. W., D. J. Touzw, A. M. Horrevorts, and A. A. Vinks. 2000. Comparative pharmacokinetics of the carbapenems: clinical implications. Clin. Pharmacokinet. 39:185-201.
18. Musson, D., A. Majumdar, S. Holland, K. Birk, P. Winckersham, and S. Li. 2004. Pharmacokinetics of total and unbound ertapenem in healthy elderly subjects. Antimicrob. Agents Chemother. 48:521-524.
19. Namias, N., J. S. Solomkin, E. H. Jensen, J. E. Tomassini, and M. A. Abramson. 2007. Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults. Surg. Infect. 8:15-28.
20. Nix, D. E., A. K. Majumdar, and M. J. DiNubile. 2004. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. J. Antimicrob. Chemother. 53:23-28.
21. Pletz, M. W., M. Rau, J. Bulitta, A. De Roux, O. Burkhardt, and G. Kruse. 2004. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob. Agents Chemother. 48:3765-3772.
22. Remington, R., and T. Hultman. 2007. Hypodermoclysis to treat dehydration: a review of the evidence. J. Am. Geriatr. Soc. 55:2051-2055.
23. Solomkin, J. S., A. E. Yellin, O. D. Rotstein, N. V. Christou, E. P. Dellinger, and J. M. Tellado. 2003. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intra-abdominal infections: results of a doubleblind, randomized comparative phase III trial. Ann. Surg. 237:235-245.